Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study

Author: Rossi Gemma Caterina Maria   Tinelli Carmine   Pasinetti Gian Maria   Fusetti Marina   Pallavicini Claudio   Stringa Massimo   Vacchi Sauro   Stringa Francesco   Bianchi Paolo Emilio  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.5, 2011-04, pp. : 685-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content